Clinical heart transplantation. Total lymphoid irradiation for resistant rejection after heart transplantation: only moderate success medium-term

J Heart Lung Transplant. 1996 Mar;15(3):231-3.

Abstract

Total lymphoid irradiation (640 cGy) was given to 19 heart and 1 heart-lung recipients on maintenance triple therapy at a mean of 4.9 +/- 4 months after transplantation (range 46 to 519 days). Mean number of treated rejection episodes before, during, and after total lymphoid irradiation was 6.4 +/- 1.7, 0.8 +/- 1.2, and 1.2 +/- 1.3 episodes per patient, respectively. During total lymphoid irradiation, 37% had at least one episode of rejection requiring treatment; after total lymphoid irradiation, 42% had no further rejection episodes, 21% had one further episode, and 37% had 2 or more episodes. Metastatic squamous cell carcinoma in one patient and coronary artery disease in three of five patients studied to date is of concern and requires longer follow-up.

MeSH terms

  • Adult
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Rejection / immunology
  • Graft Rejection / mortality
  • Graft Rejection / radiotherapy*
  • Heart Transplantation / immunology*
  • Heart-Lung Transplantation / immunology*
  • Humans
  • Immunity, Cellular / immunology
  • Immunity, Cellular / radiation effects
  • Immunosuppressive Agents / therapeutic use
  • Lymphatic Irradiation*
  • Lymphocyte Depletion*
  • Male
  • Middle Aged
  • Radiotherapy Dosage
  • Survival Analysis

Substances

  • Immunosuppressive Agents